Menu
GeneBe

chr3-141487069-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_006506.5(RASA2):​c.-15G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,261,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000073 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )

Consequence

RASA2
NM_006506.5 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.773
Variant links:
Genes affected
RASA2 (HGNC:9872): (RAS p21 protein activator 2) The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RASA2NM_006506.5 linkuse as main transcriptc.-15G>C 5_prime_UTR_variant 1/24 ENST00000286364.9
RASA2NM_001303245.3 linkuse as main transcriptc.-15G>C 5_prime_UTR_variant 1/24
RASA2NM_001303246.3 linkuse as main transcriptc.-15G>C 5_prime_UTR_variant 1/25
RASA2XM_047448652.1 linkuse as main transcriptc.-15G>C 5_prime_UTR_variant 1/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RASA2ENST00000286364.9 linkuse as main transcriptc.-15G>C 5_prime_UTR_variant 1/241 NM_006506.5 P1Q15283-2
RASA2ENST00000515549.1 linkuse as main transcriptc.-15G>C 5_prime_UTR_variant, NMD_transcript_variant 1/54

Frequencies

GnomAD3 genomes
AF:
0.0000733
AC:
11
AN:
150044
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000485
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000134
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000634
AC:
1
AN:
15774
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
8412
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000336
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000675
AC:
75
AN:
1111868
Hom.:
0
Cov.:
30
AF XY:
0.0000668
AC XY:
36
AN XY:
538734
show subpopulations
Gnomad4 AFR exome
AF:
0.0000465
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000274
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000774
Gnomad4 OTH exome
AF:
0.0000236
GnomAD4 genome
AF:
0.0000733
AC:
11
AN:
150044
Hom.:
0
Cov.:
32
AF XY:
0.0000273
AC XY:
2
AN XY:
73230
show subpopulations
Gnomad4 AFR
AF:
0.0000485
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000134
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000680

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpSep 01, 2019Variant summary: RASA2 c.-15G>C is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 6.3e-05 in 15774 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-15G>C in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Benign
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767937276; hg19: chr3-141205911; API